Clinical Observation on Bladder Tumor

Cho, Kang Seon

Abstract

A clinical observation was made on 91 of the 107 patients with bladder, tumors seen in the Department of Urology, Chonnam University Medical School during the period from January, 1971 to December, 1978. The following results were obtained : 1. During the period, 1,377 patients were hospitalized, there were 107 cases of bladder tumors giving a rate of 7.8%. 2. There were 72 males and 19 females for a ratio of 3.8: 1. In addition, 81.3% of the patients were over 50 years of age. 3. The most common symptom was gross hematuria (85.9%), with frequent urination (53.8%), dysuria (34.1%), painful urination (33.0%) and abnormal urinary stream (35.2%) also frequently seen. 4. 38.5% of the patients visited the hospital within three months after the occurrence of the initial symptom. 71.6% within 1 year and 8.8% five years after the appearance of the initial symptom. 5. Among the 91 patients, 48 (52.7%) had multiple tumors while 43 (47.3%) had single tumor. Regardless of origin, in 47 cases (51.7%) the trigone was involved and in 41 cases (45.1%) the tumor was located near the ureteral orifices. 6. Among the 87 cases in which an IVP was performed 48 cases (55.2%) revealed normal upper urinary tracts and 66 cases (75.9%) showed a filling defect in the bladder. 7. Pathologic examination, performed in 86 cases, revealed transitional cell carcinoma in 77 cases (89.5%). 8. Operation was performed on 83 patients with thirteen patients receiving more than two operations. Partial cystectomy was performed 29 times, open resection with coagulation 25 times, TUR 23 times, radical or simple total cystectomy 21 times and total urethrectomy 4 times. 9. One year after treatment, out of a total of 75 cases, 30 cases (40.0%) had follow-up studies done. Of those, 23 (76.7%) survived. Five years after treatment, out of a total of 19 cases, 11 cases (57.9%) had follow-up studies done. Of those 11. 7 (63.7%) survived. 10. Of the 39 follow-up studies, operation was performed in 37 cases with 18 (48.6%) of those patients exhibiting persistent or recurrent tumors.